Release Date: 31/07/14 15:50 Summary: Quarterly Report and Cash Flow Reports Price Sensitive: Yes Download Document 2.68MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%